The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluation of preoperative therapy for extremity soft tissue sarcomas (STS).
J. M. Meyer
No relevant relationships to disclose
K. S. Perlewitz
No relevant relationships to disclose
S. L. Hemmingson
No relevant relationships to disclose
J. B. Hayden
No relevant relationships to disclose
A. Hung
No relevant relationships to disclose
A. Mansoor
No relevant relationships to disclose
M. L. Holtorf
No relevant relationships to disclose
W. J. Woodward
No relevant relationships to disclose
C. S. Springer
No relevant relationships to disclose
W. Huang
No relevant relationships to disclose
C. W. Ryan
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Onyx; Pfizer
Honoraria - Onyx; Pfizer
Research Funding - Bayer; Johnson & Johnson; MabVax; Pfizer; ZIOPHARM Oncology